Related Experiment Video
Updated: Nov 10, 2025
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Mobile-Health Technologies for a Child Neuropsychiatry Service: Development and Usability of the Assioma Digital
Elisa Fucà1, Floriana Costanzo1, Dimitri Bonutto2
1Child and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Insights
This study introduces the Assioma m-Health platform, enhancing child and adolescent neuropsychiatry clinical pathways. The platform improved communication and family involvement, showing potential for optimized care and reduced in-person visits.
Area of Science:
- Digital health
- Child and adolescent neuropsychiatry
- Clinical pathway optimization
Background:
- m-Health platforms are increasingly vital for healthcare delivery.
- Effective communication and family involvement are crucial in pediatric mental health.
- Traditional clinical pathways can be inefficient and limit accessibility.
Purpose of the Study:
- To develop and evaluate the Assioma m-Health platform for child and adolescent neuropsychiatry.
- To enhance data collection, clinical workflow, and communication among patients, caregivers, and clinicians.
- To promote active family engagement in day hospital (DH) procedures.
Main Methods:
- Development of a multi-platform m-Health application (Assioma) for tablets, smartphones, and PCs.
- Utilized tablets for anamnesis and educational content delivery to caregivers.
- Employed smartphone app for DH pathway scheduling and desktop application for clinician data management and communication.
- Conducted usability and satisfaction testing with children, caregivers (N=24), and clinicians (N=6).
Main Results:
- High usability scores were reported by both families and clinicians.
- Overall satisfaction was high, with 50% of families and 33% of clinicians expressing satisfaction.
- The platform facilitated data collection, communication, and family involvement in DH procedures.
Conclusions:
- The Assioma platform demonstrates potential to optimize clinical pathways in child and adolescent neuropsychiatry.
- It can enhance compliance, clinical efficiency, and support social distancing by reducing in-person contacts.
- The platform is a valuable tool for improving pediatric mental healthcare delivery, especially during public health crises like the COVID-19 pandemic.
Abstract:
We developed an m-Health platform to support clinical pathways in a child and adolescent neuropsychiatry unit. The Assioma platform was created for tablets, smartphones and PCs, to support data collection and clinical workflow, to promote constant communication between patients, caregivers and clinicians, and to promote active family involvement in day hospital (DH) procedures. Through the Assioma application for tablets, caregivers filled out an anamnestic questionnaire and explored contents on the DH procedures and neurodevelopmental conditions. The application for smartphones included an agenda function for the DH pathways. Through the application for desktops, clinicians could export anamnestic information in text and Excel formats, send real-time notifications, and push relative contents to families' account. We tested the usability and satisfaction of the Assioma platform in a group of children, caregivers (N = 24) and clinicians (N = 6). Both families and clinicians gave high scores to almost all usability items. The overall satisfaction reached the highest levels at 50% satisfied for families and at 33% for clinicians. Our results indicate that the Assioma platform has the potential to optimize clinical pathways, increasing compliance and clinical efficiency, and to reduce in-person contacts supporting social distancing for clinical pathways, a crucial need during the COVID-19 pandemic.
